At the point when the characterized heftiness pathways were contrasted with the characterized non-insulin-subordinate diabetes mellitus (NIDDM)- applicable pathways, it was found that the corpulence important pathways contain a quality set identified with the insulin receptor and that the NIDDM-pertinent quality set contains qualities that are 2-overlap up-managed by insulin. The gene discussed is INS; the disease is type 2 diabetes mellitus.